These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 38452738)
1. Global Prevalence of Preexisting Antibodies against Human Adenoviruses, Surveyed from 1962 to 2021. Luo H; Zhou Q; Feng J; Wu Y; Chen H; Mao M; Qi R Intervirology; 2024; 67(1):19-39. PubMed ID: 38452738 [TBL] [Abstract][Full Text] [Related]
2. Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 Pandemic. Wang X; Kerkmann L; Hetzel M; Windmann S; Trilling M; Zhang W; Ehrhardt A; Bayer W J Virol; 2022 Nov; 96(22):e0113322. PubMed ID: 36342295 [TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of Neutralizing Antibodies against Six Human Adenovirus Types Indicates the Low Level of Herd Immunity in Young Children from Guangzhou, China. Tian X; Fan Y; Wang C; Liu Z; Liu W; Xu Y; Mo C; You A; Li X; Rong X; Zhou R Virol Sin; 2021 Jun; 36(3):373-381. PubMed ID: 33165772 [TBL] [Abstract][Full Text] [Related]
4. A review of 65 years of human adenovirus seroprevalence. Mennechet FJD; Paris O; Ouoba AR; Salazar Arenas S; Sirima SB; Takoudjou Dzomo GR; Diarra A; Traore IT; Kania D; Eichholz K; Weaver EA; Tuaillon E; Kremer EJ Expert Rev Vaccines; 2019 Jun; 18(6):597-613. PubMed ID: 31132024 [No Abstract] [Full Text] [Related]
5. Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon. Haque E; Banik U; Monowar T; Anthony L; Adhikary AK PLoS One; 2018; 13(3):e0194516. PubMed ID: 29590206 [TBL] [Abstract][Full Text] [Related]
6. Detection of antibodies against adenovirus protein IX, fiber, and hexon in human sera by immunoblot assay. Bauer U; Flunker G; Bruss K; Kallwellis K; Liebermann H; Luettich T; Motz M; Seidel W J Clin Microbiol; 2005 Sep; 43(9):4426-33. PubMed ID: 16145087 [TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults. Zhang S; Huang W; Zhou X; Zhao Q; Wang Q; Jia B J Med Virol; 2013 Jun; 85(6):1077-84. PubMed ID: 23588735 [TBL] [Abstract][Full Text] [Related]
8. Seroepidemiological investigation of HAdV-4 infection among healthy adults in China and in Sierra Leone, West Africa. Wang B; Li J; Wu S; Chen Y; Zhang Z; Zhai Y; Guo Q; Zhang J; Song X; Zhao Z; Hou L; Chen W Emerg Microbes Infect; 2018 Dec; 7(1):200. PubMed ID: 30514848 [TBL] [Abstract][Full Text] [Related]
9. Detection of enteric- and non-enteric adenoviruses in gastroenteritis patients, Bangladesh, 2012-2015. Afrad MH; Avzun T; Haque J; Haque W; Hossain ME; Rahman AR; Ahmed S; Faruque ASG; Rahman MZ; Rahman M J Med Virol; 2018 Apr; 90(4):677-684. PubMed ID: 29244212 [TBL] [Abstract][Full Text] [Related]
10. A Murine Monoclonal Antibody With Potent Neutralization Ability Against Human Adenovirus 7. Wang R; Lu J; Zhou Q; Chen L; Huang Y; Yu Y; Yang Z Front Cell Infect Microbiol; 2019; 9():417. PubMed ID: 31867291 [TBL] [Abstract][Full Text] [Related]
11. Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors. Piedra PA; Poveda GA; Ramsey B; McCoy K; Hiatt PW Pediatrics; 1998 Jun; 101(6):1013-9. PubMed ID: 9606228 [TBL] [Abstract][Full Text] [Related]
12. Infection of Bronchial Epithelial Cells by the Human Adenoviruses A12, B3, and C2 Differently Regulates the Innate Antiviral Effector APOBEC3B. Lejeune N; Poulain F; Willemart K; Blockx Z; Mathieu S; Gillet NA J Virol; 2021 Jun; 95(13):e0241320. PubMed ID: 33853956 [TBL] [Abstract][Full Text] [Related]
13. Human adenovirus among hospitalized children with respiratory tract infections in Beijing, China, 2017-2018. Yao LH; Wang C; Wei TL; Wang H; Ma FL; Zheng LS Virol J; 2019 Jun; 16(1):78. PubMed ID: 31196108 [TBL] [Abstract][Full Text] [Related]
14. Development of two antigen-binding fragments to a conserved linear epitope of human adenovirus and their application in immunofluorescence. Liu Z; Tian X; Liu W; Xian Y; Chen W; Chen H; Zhou R PLoS One; 2019; 14(6):e0219091. PubMed ID: 31242267 [TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Patients with Neuromuscular Disorders. Klann PJ; Wang X; Elfert A; Zhang W; Köhler C; Güttsches AK; Jacobsen F; Weyen U; Roos A; Ehrke-Schulz E; Ehrhardt A; Vorgerd M; Bayer W Viruses; 2022 Dec; 15(1):. PubMed ID: 36680119 [TBL] [Abstract][Full Text] [Related]
16. Molecular typing of human adenoviruses among hospitalized patients with respiratory tract infections in a tertiary Hospital in Guangzhou, China between 2017 and 2019. Wang X; Wang D; Umar S; Qin S; Ling Q; Gray GC; Liu Y BMC Infect Dis; 2021 Aug; 21(1):748. PubMed ID: 34344310 [TBL] [Abstract][Full Text] [Related]
17. A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55. Liu T; Zhou Z; Tian X; Liu W; Xu D; Fan Y; Liao J; Gu S; Li X; Zhou R Vaccine; 2018 Apr; 36(16):2199-2206. PubMed ID: 29548605 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of antibodies to adenovirus serotypes 4 and 7 among unimmunized US Army trainees: results of a retrospective nationwide seroprevalence survey. Ludwig SL; Brundage JF; Kelley PW; Nang R; Towle C; Schnurr DP; Crawford-Miksza L; Gaydos JC J Infect Dis; 1998 Dec; 178(6):1776-8. PubMed ID: 9815232 [TBL] [Abstract][Full Text] [Related]
19. High prevalence of species D human adenoviruses in fecal specimens from Urban Kenyan children with diarrhea. Magwalivha M; Wolfaardt M; Kiulia NM; van Zyl WB; Mwenda JM; Taylor MB J Med Virol; 2010 Jan; 82(1):77-84. PubMed ID: 19950234 [TBL] [Abstract][Full Text] [Related]
20. International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials. Mast TC; Kierstead L; Gupta SB; Nikas AA; Kallas EG; Novitsky V; Mbewe B; Pitisuttithum P; Schechter M; Vardas E; Wolfe ND; Aste-Amezaga M; Casimiro DR; Coplan P; Straus WL; Shiver JW Vaccine; 2010 Jan; 28(4):950-7. PubMed ID: 19925902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]